Harvard's Tips For Coping With Prostate Enlargement

After the age of 25, the male prostate gland begins to enlarge.  This natural process is called benign prostatic hyperplasia, or BPH.  The enlargement, in itself, does not lead to cancer.  50-60% of men may never develop any symptoms, but the most common are: hesitant or weak urination, urgency or leaking, incomplete emptying, or more frequent urination.

Harvard Health Publications reports on the treatment of the condition, from various medications to surgery, and also offers lifestyle changing tips to reduce symptoms:

• stress reduction through regular exercise and relaxation techniques
• taking the necessary time to void completely when urinating
• adjust medication intake in consultation with your physician
• reduce evening fluid intake, especially caffeine and alcohol

Source: Harvard Medical School 2014 Annual Report on Prostate Diseases

Robert G. Tupac, DDS, FACP, Inc.,
Diplomate, American Board of Prosthodontics
(661) 325-1275 | www.drtupac.com
5060 California Ave., #170, Bakersfield, CA 93309

Pinning Down Prostate Cancer Risk

The British Medical Journal has recently published a controlled study of over 21,000 men between the ages of 40 and 55, to determine the association of PSA scores during that age range and subsequent risk of prostate cancer metastasis and mortality.  They found that PSA concentration can be used to predict long term (up to 25 or 30 years) risk of metastasis or death from prostate cancer.   They found that testing before the age of 45 was not diagnostic.  They found that, for those with below average PSA scores before age 55, screening was necessary only every 10 years.  They found that the group with the highest scores before age 55 required closer and more frequent screening to enable the disease to be treated as soon as possible.

Source:  www.bmj.com

Robert G. Tupac, DDS, FACP, Inc., Diplomate, American Board of Prosthodontics (661) 325-1275 | www.drtupac.com 5060 California Ave., #170, Bakersfield, CA 93309

Pinning Down Prostate Cancer Risk

The British Medical Journal has recently published a controlled study of over 21,000 men between the ages of 40 and 55, to determine the association of PSA scores during that age range and subsequent risk of prostate cancer metastasis and mortality.  They found that PSA concentration can be used to predict long term (up to 25 or 30 years) risk of metastasis or death from prostate cancer.   They found that testing before the age of 45 was not diagnostic.  They found that, for those with below average PSA scores before age 55, screening was necessary only every 10 years.  They found that the group with the highest scores before age 55 required closer and more frequent screening to enable the disease to be treated as soon as possible.

Source:  www.bmj.com

Robert G. Tupac, DDS, FACP, Inc., Diplomate, American Board of Prosthodontics (661) 325-1275 | www.drtupac.com 5060 California Ave., #170, Bakersfield, CA 93309